JPMorgan Chase & Co’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15M | Sell |
|
|||||
|
2025
Q1 | $12.9M | Sell |
|
|||||
|
2024
Q4 | $20.5M | Sell |
|
|||||
|
2024
Q3 | $39.1M | Buy |
|
|||||
|
2024
Q2 | $25.8M | Buy |
|
|||||
|
2024
Q1 | $30.9M | Sell |
|
|||||
|
2023
Q4 | $66.8M | Buy |
|
|||||
|
2023
Q3 | $43.2M | Buy |
|
|||||
|
2023
Q2 | $62.7M | Buy |
|
|||||
|
2023
Q1 | $70.8M | Sell |
|
|||||
|
2022
Q4 | $66.8M | Sell |
|
|||||
|
2022
Q3 | $112M | Buy |
|
|||||
|
2022
Q2 | $82.8M | Buy |
|
|||||
|
2022
Q1 | $98M | Sell |
|
|||||
|
2021
Q4 | $103M | Buy |
|
|||||
|
2021
Q3 | $45M | Buy |
|
|||||
|
2021
Q2 | $52.1M | Buy |
|
|||||
|
2021
Q1 | $47.7M | Buy |
|
|||||
|
2020
Q4 | $53.6M | Buy |
|
|||||
|
2020
Q3 | $48.6M | Buy |
|